Literature DB >> 17515612

Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters.

Miltiadis Kininis1, Benjamin S Chen, Adam G Diehl, Gary D Isaacs, Tong Zhang, Adam C Siepel, Andrew G Clark, W Lee Kraus.   

Abstract

To explore the global mechanisms of estrogen-regulated transcription, we used chromatin immunoprecipitation coupled with DNA microarrays to determine the localization of RNA polymerase II (Pol II), estrogen receptor alpha (ERalpha), steroid receptor coactivator proteins (SRC), and acetylated histones H3/H4 (AcH) at estrogen-regulated promoters in MCF-7 cells with or without estradiol (E2) treatment. In addition, we correlated factor occupancy with gene expression and the presence of transcription factor binding elements. Using this integrative approach, we defined a set of 58 direct E2 target genes based on E2-regulated Pol II occupancy and classified their promoters based on factor binding, histone modification, and transcriptional output. Many of these direct E2 target genes exhibit interesting modes of regulation and biological activities, some of which may be relevant to the onset and proliferation of breast cancers. Our studies indicate that about one-third of these direct E2 target genes contain promoter-proximal ERalpha-binding sites, which is considerably more than previous estimates. Some of these genes represent possible novel targets for regulation through the ERalpha/AP-1 tethering pathway. Our studies have also revealed several previously uncharacterized global features of E2-regulated gene expression, including strong positive correlations between Pol II occupancy and AcH levels, as well as between the E2-dependent recruitment of ERalpha and SRC at the promoters of E2-stimulated genes. Furthermore, our studies have revealed new mechanistic insights into E2-regulated gene expression, including the absence of SRC binding at E2-repressed genes and the presence of constitutively bound, promoter-proximally paused Pol IIs at some E2-regulated promoters. These mechanistic insights are likely to be relevant for understanding gene regulation by a wide variety of nuclear receptors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17515612      PMCID: PMC1951957          DOI: 10.1128/MCB.00083-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

Review 1.  Cytochrome P450-mediated metabolism of estrogens and its regulation in human.

Authors:  Yuki Tsuchiya; Miki Nakajima; Tsuyoshi Yokoi
Journal:  Cancer Lett       Date:  2004-11-19       Impact factor: 8.679

2.  A high-resolution map of active promoters in the human genome.

Authors:  Tae Hoon Kim; Leah O Barrera; Ming Zheng; Chunxu Qu; Michael A Singer; Todd A Richmond; Yingnian Wu; Roland D Green; Bing Ren
Journal:  Nature       Date:  2005-06-29       Impact factor: 49.962

Review 3.  Constructing transcriptional regulatory networks.

Authors:  Alexandre Blais; Brian David Dynlacht
Journal:  Genes Dev       Date:  2005-07-01       Impact factor: 11.361

4.  From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.

Authors:  Josée Laganière; Geneviève Deblois; Céline Lefebvre; Alain R Bataille; François Robert; Vincent Giguère
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-08       Impact factor: 11.205

5.  Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1.

Authors:  Jason S Carroll; X Shirley Liu; Alexander S Brodsky; Wei Li; Clifford A Meyer; Anna J Szary; Jerome Eeckhoute; Wenlin Shao; Eli V Hestermann; Timothy R Geistlinger; Edward A Fox; Pamela A Silver; Myles Brown
Journal:  Cell       Date:  2005-07-15       Impact factor: 41.582

6.  Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking.

Authors:  Qianben Wang; Jason S Carroll; Myles Brown
Journal:  Mol Cell       Date:  2005-09-02       Impact factor: 17.970

7.  Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters.

Authors:  Alfred S L Cheng; Victor X Jin; Meiyun Fan; Laura T Smith; Sandya Liyanarachchi; Pearlly S Yan; Yu-Wei Leu; Michael W Y Chan; Christoph Plass; Kenneth P Nephew; Ramana V Davuluri; Tim H-M Huang
Journal:  Mol Cell       Date:  2006-02-03       Impact factor: 17.970

8.  Identification of target genes in breast cancer cells directly regulated by the SRC-3/AIB1 coactivator.

Authors:  Paul Labhart; Sudipan Karmakar; Eleni M Salicru; Brian S Egan; Vassilios Alexiadis; Bert W O'Malley; Carolyn L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-26       Impact factor: 11.205

9.  Identifying estrogen receptor alpha target genes using integrated computational genomics and chromatin immunoprecipitation microarray.

Authors:  Victor X Jin; Yu-Wei Leu; Sandya Liyanarachchi; Hao Sun; Meiyun Fan; Kenneth P Nephew; Tim H-M Huang; Ramana V Davuluri
Journal:  Nucleic Acids Res       Date:  2004-12-17       Impact factor: 16.971

Review 10.  Estrogen receptors and human disease.

Authors:  Bonnie J Deroo; Kenneth S Korach
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

View more
  107 in total

1.  Research resource: enhanced genome-wide occupancy of estrogen receptor α by the cochaperone p23 in breast cancer cells.

Authors:  Natalie E Simpson; Jason Gertz; Keren Imberg; Richard M Myers; Michael J Garabedian
Journal:  Mol Endocrinol       Date:  2011-11-10

2.  Regulation of poly(ADP-ribose) polymerase-1-dependent gene expression through promoter-directed recruitment of a nuclear NAD+ synthase.

Authors:  Tong Zhang; Jhoanna G Berrocal; Jie Yao; Michelle E DuMond; Raga Krishnakumar; Donald D Ruhl; Keun Woo Ryu; Matthew J Gamble; W Lee Kraus
Journal:  J Biol Chem       Date:  2012-02-13       Impact factor: 5.157

Review 3.  Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation.

Authors:  Raj Kumar; Iain J McEwan
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

4.  Activation of estrogen receptor α by raloxifene through an activating protein-1-dependent tethering mechanism in human cervical epithelial cancer cells: a role for c-Jun N-terminal kinase.

Authors:  Elizabeth A Fogarty; Christina K Matulis; W Lee Kraus
Journal:  Mol Cell Endocrinol       Date:  2011-09-22       Impact factor: 4.102

Review 5.  Estrogen signaling via estrogen receptor {beta}.

Authors:  Chunyan Zhao; Karin Dahlman-Wright; Jan-Åke Gustafsson
Journal:  J Biol Chem       Date:  2010-10-18       Impact factor: 5.157

Review 6.  Cellular and molecular mechanisms of sexual differentiation in the mammalian nervous system.

Authors:  Nancy G Forger; J Alex Strahan; Alexandra Castillo-Ruiz
Journal:  Front Neuroendocrinol       Date:  2016-01-11       Impact factor: 8.606

Review 7.  Epigenetic mechanisms in sexual differentiation of the brain and behaviour.

Authors:  Nancy G Forger
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-02-01       Impact factor: 6.237

8.  Inhibition of BET proteins impairs estrogen-mediated growth and transcription in breast cancers by pausing RNA polymerase advancement.

Authors:  Surojeet Sengupta; Michael C Biarnes; Robert Clarke; V Craig Jordan
Journal:  Breast Cancer Res Treat       Date:  2015-02-27       Impact factor: 4.872

9.  Estrogen receptor alpha (ERalpha) mediates stimulatory effects of estrogen on aromatase (CYP19) gene expression in human placenta.

Authors:  Premlata Kumar; Amrita Kamat; Carole R Mendelson
Journal:  Mol Endocrinol       Date:  2009-03-19

10.  SAFB1 mediates repression of immune regulators and apoptotic genes in breast cancer cells.

Authors:  Stephanie Hammerich-Hille; Benny A Kaipparettu; Anna Tsimelzon; Chad J Creighton; Shiming Jiang; Jose M Polo; Ari Melnick; Rene Meyer; Steffi Oesterreich
Journal:  J Biol Chem       Date:  2009-11-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.